CKD Bio

CKD Bio EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of CKD Bio (063160.KS) as of Oct 19, 2026 is -12.11. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 17.99 — a change of -167.30% (lower).

EV/FCF

-12.11

YoY

-167.30%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of CKD Bio is 2025 -12.11 . EV/FCF (Enterprise Value to Free Cash Flow) of CKD Bio was 2024 17.99 . It decreases by -167.30% lower compared to the previous year.

The CKD Bio EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-139.88 KRW
Jan 1, 2019
-4.68 KRW
Jan 1, 2020
-3.07 KRW
Jan 1, 2021
-7.76 KRW
Jan 1, 2022
-20.83 KRW
Jan 1, 2023
-10.27 KRW
Jan 1, 2024
17.99 KRW
Jan 1, 2025
-12.11 KRW
The CKD Bio EV/FCF history
YEAREV/FCFYoY
-12.11-167.30%
17.99-275.15%
-10.27-50.68%
-20.83+168.21%
-7.76+152.65%
-3.07-34.34%
-4.68-96.65%
-139.88-1,340.29%
11.28-57.71%
26.67-95.62%
609.06+4,293.77%
13.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

CKD Bio Stock analysis

What does CKD Bio do? CKD Bio Corp, headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in pharmaceuticals. The company develops and manufactures active pharmaceutical ingredients, including antibiotic components like DMCTs and rifampicins, immunosuppressive agents such as cyclosporin and tacrolimus, and diabetes remedies like acarbose. Products are distributed domestically and internationally across markets in America, China, Europe, Africa, Southeast Asia, Latin America, and the Middle East. Listed on 11 December 2001. CKD Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CKD Bio stock

EV/FCF (Enterprise Value to Free Cash Flow) of CKD Bio is -12.11 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of CKD Bio changed from 17.99 to -12.11, representing a -167.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) CKD Bio since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s CKD Bio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — CKD Bio

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — CKD Bio